Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer (Q83419012)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324516%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324516%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

10

Steven A Narod

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324516%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Shiyu Zhang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324516%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Robert Royer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324516%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Song Li

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324516%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

John R McLaughlin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324516%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Barry Rosen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324516%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Harvey A Risch

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324516%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Isabel Fan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324516%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Linda Bradley

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324516%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Patricia A Shaw

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324516%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

15 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324516%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324516%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

121

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324516%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324516%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

353-357

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324516%20AND%20SRC:MED&resulttype=core&format=json

Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada

22 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.020

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.020

Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.020

BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.020

Founder BRCA1 and BRCA2 mutations in French Canadian ovarian cancer cases unselected for family history

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.020

A rapid fluorescent multiplexed-PCR analysis (FMPA) for founder mutations in the BRCA1 and BRCA2 genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.020

The Exon 13 Duplication in the BRCA1 Gene Is a Founder Mutation Present in Geographically Diverse Populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.020

Mutation screening using fluorescence multiplex denaturing gradient gel electrophoresis (FMD): detecting mutations in the BRCA1 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.020

Identification of specific BRCA1 and BRCA2 variants by DHPLC

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.020

Large genomic deletions inactivate the BRCA2 gene in breast cancer families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.020

Cancer variation associated with the position of the mutation in the BRCA2 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.020

The BRCA1 exon 13 duplication in the Swedish population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.020

Parity, Oral Contraceptives, and the Risk of Ovarian Cancer among Carriers and Noncarriers of aBRCA1orBRCA2Mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.020

Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.020

Clinicopathologic features of BRCA-linked and sporadic ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.020

Uptake of clinical genetic testing for ovarian cancer in Ontario: a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.020

Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.020

Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.020

Improved survival in women with BRCA-associated ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.020

“BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated WithBRCA1andBRCA2Mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.020

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.020

10.1016/J.YGYNO.2011.01.020

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324516%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference